Cover Image

Efficacy, safety and therapeutic mechanism of Shen-Qi Xiao-Tan formula in the treatment of peripheral atherosclerosis in patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial protocol

Abstract Background Peripheral atherosclerosis is a common macrovascular complication of diabetes, but the treatment is limited. Chinese herbal medicine is the complementary and alternative therapy to delay the progression of atherosclerosis and reduce blood glucose and lipids. Shen-Qi Xiao-Tan (SQX...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yulin Leng (Author), Xiaoxu Fu (Author), Lisen Qian (Author), Qiqi Li (Author), Hong Gao (Author), Hongyan Xie (Author), Chunguang Xie (Author)
Format:	Book
Published:	BMC, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Investigation of the hypoglycemic mechanism of the ShenQi compound formula through metabonomics and 16S rRNA sequencing
by: Juan Gao, et al.
Published: (2024)

The efficacy and safety of Chinese herbal medicine as an add-on therapy for type 2 diabetes mellitus patients with carotid atherosclerosis: An updated meta-analysis of 27 randomized controlled trials
by: Zehua Zhang, et al.
Published: (2023)

Qing-Re-Xiao-Zheng-Yi-Qi formula relieves kidney damage and activates mitophagy in diabetic kidney disease
by: Qiaoru Wu, et al.
Published: (2022)

QiShenYiQi pill for myocardial collagen metabolism and apoptosis in rats of autoimmune cardiomyopathy
by: Shichao Lv, et al.
Published: (2022)

Chemical characterization and metabolic profiling of Xiao-Er-An-Shen Decoction by UPLC-QTOF/MS
by: Ruipei Yang, et al.
Published: (2023)

The potential of astragalus polysaccharide for treating diabetes and its action mechanism
by: Shiyu Liu, et al.
Published: (2024)

The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis
by: Zehua Zhang, et al.
Published: (2022)

Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model
by: Yule Wang, et al.
Published: (2021)

QiShenYiQi Inhibits Tissue Plasminogen Activator-Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice
by: Yang Ye, et al.
Published: (2022)

Cardioprotection against ischemia/reperfusion injury by QiShenYiQi Pill® via ameliorate of multiple mitochondrial dysfunctions
by: Chen JR, et al.
Published: (2015)

Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

UHPLC-Q-Orbitrap HRMS and network analysis to explore the mechanisms of QiShenYiQi dripping pill for treating myocardial infarction
by: Zhichao Liu, et al.
Published: (2024)

QiShenYiQi pills, a Chinese patent medicine, increase bioavailability of atorvastatin by inhibiting Mrp2 expression in rats
by: Congyang Ding, et al.
Published: (2022)

Effects of Qi Teng Xiao Zhuo granules on circRNA expression profiles in rats with chronic glomerulonephritis
by: Gao JR, et al.
Published: (2019)

On "Pestilences" in an Ancient Vietnamese Medical Book, Nan Yao Shen Xiao (《南药神效》Miraculous Vietnamese Medicine)
by: Lina Yang, et al.
Published: (2020)

Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities
by: Jun Zhang, et al.
Published: (2022)

Jin-Gui-Shen-Qi Wan ameliorates diabetic retinopathy by inhibiting apoptosis of retinal ganglion cells through the Akt/HIF-1α pathway
by: Dan Liang, et al.
Published: (2023)

QiShenYiQi Pill Ameliorates Cardiac Fibrosis After Pressure Overload-Induced Cardiac Hypertrophy by Regulating FHL2 and the Macrophage RP S19/TGF-β1 Signaling Pathway
by: Gulinigaer Anwaier, et al.
Published: (2022)

ShenQi FuZheng injection as an adjunctive treatment to chemotherapy in breast cancer patients: a meta-analysis
by: Hongbo Zhang, et al.
Published: (2019)

Identification of Rab7 as an autophagy marker: potential therapeutic approaches and the effect of Qi Teng Xiao Zhuo granule in chronic glomerulonephritis
by: Xiujuan Qin, et al.
Published: (2023)

Yi-Qi-Jian-Pi-Xiao-Yu-Xie-Zhuo Formula Improves Muscle Atrophy via Modulating the IGF-1/PI3K/Akt Signaling Pathway in 5/6 Nephrectomized Rats
by: Hong Xia, et al.
Published: (2021)

An Integrated Pharmacology-Based Analysis for Antidepressant Mechanism of Chinese Herbal Formula Xiao-Yao-San
by: Naijun Yuan, et al.
Published: (2020)

ShenQiWan ameliorates renal injury in type 2 diabetic mice by modulating mitochondrial fusion and endoplasmic reticulum stress
by: Wei Xiong, et al.
Published: (2023)

Chinese herbal medicine and active ingredients for diabetic cardiomyopathy: molecular mechanisms regulating endoplasmic reticulum stress
by: Lianjun Ao, et al.
Published: (2023)

Target Identification of Active Constituents of Shen Qi Wan to Treat Kidney Yang Deficiency Using Computational Target Fishing and Network Pharmacology
by: Jie Ying Zhang, et al.
Published: (2019)

Exploring the Mechanisms of Modified Bu-Shen-Yi-Qi Decoction for COPD-Related Osteoporosis Therapy via Transcriptomics and Network Pharmacology Approach
by: Zhong Y, et al.
Published: (2023)

Xiao Cheng Qi Decoction, an Ancient Chinese Herbal Mixture, Relieves Loperamide-Induced Slow-Transit Constipation in Mice: An Action Mediated by Gut Microbiota
by: Amanguli Tuohongerbieke, et al.
Published: (2024)

Efficacy and safety of modified Xiao-Feng Powder in the treatment of chronic urticaria: protocol of a randomized double-blind placebo-controlled study
by: Hing Yu Hung, et al.
Published: (2022)

A Chinese Herbal Formulation, Xiao-Er-An-Shen Decoction, Attenuates Tourette Syndrome, Possibly by Reversing Abnormal Changes in Neurotransmitter Levels and Enhancing Antioxidant Status in Mouse Brain
by: Jihang Chen, et al.
Published: (2019)

Shen’ge Formula Protects Cardiac Function in Rats with Pressure Overload-Induced Heart Failure
by: Qiu B, et al.
Published: (2024)

Ren-Shen-Bu-Qi decoction alleviates exercise fatigue through activating PI3K/AKT/Nrf2 pathway in mice
by: Yangyang Chen, et al.
Published: (2024)

Effects of Xiao Chengqi Formula on Slow Transit Constipation by Assessing Gut Microbiota and Metabolomics Analysis in vitro and in vivo
by: Qian Zhou, et al.
Published: (2022)

Modified BuShenYiQi formula alleviates experimental allergic asthma in mice by negative regulation of type 2 innate lymphoid cells and CD4+ type 9 helper T cells and the VIP-VPAC2 signalling pathway
by: Muhua Huang, et al.
Published: (2021)

Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway
by: Zhao M, et al.
Published: (2024)

Evidence and Potential Mechanisms of Jin-Gui Shen-Qi Wan as a Treatment for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Zhipeng Hu, et al.
Published: (2021)

Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
by: Yuanyuan Zhong, et al.
Published: (2022)

Network pharmacology and experimental analysis to reveal the mechanism of Dan-Shen-Yin against endothelial to mesenchymal transition in atherosclerosis
by: Mengyun Hong, et al.
Published: (2022)

First person - Xiao Li
Published: (2022)

Corrigendum: Effects of Xiao Chengqi formula on slow transit constipation by assessing gut microbiota and metabolomics analysis in vitro and in vivo
by: Qian Zhou, et al.
Published: (2023)

Jian-Pi-Yi-Shen Formula ameliorates chronic kidney disease: involvement of mitochondrial quality control network
by: Xinhui Liu, et al.
Published: (2018)